Pharmamarketeer

Abbott introduces new DRG Invisible Trial System for chronic pain management

Abbott has announced the launch of the new DRG Invisible Trial System, which is approved by the US Food and Drug Administration (FDA) and received CE Mark in Europe.

Medhc-fases-banner
Advertentie(s)